leukemia Active surveillance Carcinoma Grade 3, 4, or 5 Palliation Monoclonal antibody Clinical stage Antibody Drug Conjugate (ADCs) Complete remission CTACAE Partial Remission Pathological stage Relapse Recurrence Cellular therapy Complementary therapy Adenocarcinoma performance status Tumor Adjuvant treatment Maintenance chemotherapy Surgical margin Tyrosine kinase inhibitors (TKIs) Chemotherapy Definitive treatment TNM staging system Neoadjuvant treatment Minimal residual disease (MRD) Maintenance chemotherapy ECOG performance status Cure Refractory Sarcoma Checkpoint inhibitor leukemia Active surveillance Carcinoma Grade 3, 4, or 5 Palliation Monoclonal antibody Clinical stage Antibody Drug Conjugate (ADCs) Complete remission CTACAE Partial Remission Pathological stage Relapse Recurrence Cellular therapy Complementary therapy Adenocarcinoma performance status Tumor Adjuvant treatment Maintenance chemotherapy Surgical margin Tyrosine kinase inhibitors (TKIs) Chemotherapy Definitive treatment TNM staging system Neoadjuvant treatment Minimal residual disease (MRD) Maintenance chemotherapy ECOG performance status Cure Refractory Sarcoma Checkpoint inhibitor
(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.
leukemia
Active surveillance
Carcinoma
Grade 3, 4, or 5
Palliation
Monoclonal antibody
Clinical stage
Antibody Drug Conjugate (ADCs)
Complete remission
CTACAE
Partial Remission
Pathological stage
Relapse
Recurrence
Cellular therapy
Complementary therapy
Adenocarcinoma
performance status
Tumor
Adjuvant treatment
Maintenance chemotherapy
Surgical margin
Tyrosine kinase inhibitors (TKIs)
Chemotherapy
Definitive treatment
TNM staging system
Neoadjuvant treatment
Minimal residual disease (MRD)
Maintenance chemotherapy
ECOG performance status
Cure
Refractory
Sarcoma
Checkpoint inhibitor